BOT 3.13% 38.8¢ botanix pharmaceuticals ltd

"The BTX 1801 Phase 2a clinical study is poised to commence...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 528 Posts.
    lightbulb Created with Sketch. 180
    "The BTX 1801 Phase 2a clinical study is poised to commence enrolment in Western Australia in the
    coming weeks" - "with the study"expected to be completed by early 4Q CY2020 with data available soon thereafter."

    Soon my beauties.. SOON we shall be rewarded.. (hopefully tongue.png)

    https://hotcopper.com.au/data/attachments/2336/2336482-43e880f7b6ae4898b63e15e5bd6bb2d5.jpg

 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.